- Home
- PCRX vs CCEC Comparison
PCRX vs CCEC Comparison
Compare PCRX & CCEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- CCEC
- Stock Information
- Founded
- PCRX 2006
- CCEC 2007
- Country
- PCRX United States
- CCEC Greece
- Employees
- PCRX N/A
- CCEC N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- CCEC Marine Transportation
- Sector
- PCRX Health Care
- CCEC Consumer Discretionary
- Exchange
- PCRX Nasdaq
- CCEC Nasdaq
- Market Cap
- PCRX 1.2B
- CCEC 1.2B
- IPO Year
- PCRX 2011
- CCEC 2007
- Fundamental
- Price
- PCRX $23.96
- CCEC $19.93
- Analyst Decision
- PCRX Strong Buy
- CCEC Buy
- Analyst Count
- PCRX 6
- CCEC 2
- Target Price
- PCRX $33.83
- CCEC $26.00
- AVG Volume (30 Days)
- PCRX 769.6K
- CCEC 12.8K
- Earning Date
- PCRX 11-06-2025
- CCEC 10-30-2025
- Dividend Yield
- PCRX N/A
- CCEC 3.00%
- EPS Growth
- PCRX N/A
- CCEC 304.00
- EPS
- PCRX 0.47
- CCEC 4.79
- Revenue
- PCRX $716,791,000.00
- CCEC $421,795,000.00
- Revenue This Year
- PCRX $7.27
- CCEC $16.66
- Revenue Next Year
- PCRX $10.18
- CCEC $14.48
- P/E Ratio
- PCRX $50.52
- CCEC $7.79
- Revenue Growth
- PCRX 3.14
- CCEC 32.74
- 52 Week Low
- PCRX $16.29
- CCEC $14.09
- 52 Week High
- PCRX $27.64
- CCEC $24.83
- Technical
- Relative Strength Index (RSI)
- PCRX 56.14
- CCEC 46.06
- Support Level
- PCRX $22.29
- CCEC $18.56
- Resistance Level
- PCRX $24.95
- CCEC $20.45
- Average True Range (ATR)
- PCRX 1.23
- CCEC 0.93
- MACD
- PCRX 0.09
- CCEC -0.00
- Stochastic Oscillator
- PCRX 78.19
- CCEC 49.76
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About CCEC Capital Clean Energy Carriers Corp. Common Share
Capital Clean Energy Carriers Corp is an international shipping company. It is the platform of gas carriage solutions with a focus on the energy transition. The company owns 20 high-specification vessels, including 12 latest-generation LNG carriers (LNG/Cs) and eight legacy Neo-Panamax container vessels.